Schorno Dean L 4
4 · RIGEL PHARMACEUTICALS INC · Filed Jan 25, 2024
Insider Transaction Report
Form 4
Schorno Dean L
EVP & Chief Financial Officer
Transactions
- Award
Common Stock
2024-01-23+209,000→ 415,519 total - Award
Employee Stock Option (Right to Buy)
2024-01-23+157,000→ 157,000 totalExercise: $1.27Exp: 2034-01-23→ Common Stock (157,000 underlying)
Footnotes (3)
- [F1]The shares of common stock are to be acquired upon the vesting of a Restricted Stock Unit award granted to the Reporting Person. The Restricted Stock Units shall vest annually over three (3) years from February 1, 2024, with the first annual vest occurring on February 1, 2025.
- [F2]Includes 10,000 shares acquired under the Issuer's stock purchase plan.
- [F3]The shares of common stock subject to the option vest monthly over three (3) years from the vesting commencement date of January 23, 2024, subject to the Reporting Person's continuous service to the issuer through each such period.